NCT03007745

Brief Summary

Although obstructive sleep apnea, a breathing disorder during sleep, is prevalent and recognized as a major public health concern, most Veterans with this disorder are undiagnosed and therefore untreated. Access to sleep laboratories for testing is limited particularly for those Veterans living in rural areas and Veterans with disabilities that prevent travel to a sleep center. The goal of this study is to compare a web-based telehealth management strategy to in-person management. The telehealth pathway will enable Veterans to be diagnosed and treated without visiting a sleep center. The investigators believe that telehealth management will increase Veterans' access to this specialized care at a cost that is less than in-person delivery but with similar improvements in daytime function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
435

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 29, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 2, 2017

Completed
10 months until next milestone

Study Start

First participant enrolled

October 24, 2017

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2021

Completed
4.2 years until next milestone

Results Posted

Study results publicly available

April 29, 2025

Completed
Last Updated

May 20, 2025

Status Verified

May 1, 2025

Enrollment Period

3.3 years

First QC Date

December 29, 2016

Results QC Date

January 27, 2025

Last Update Submit

May 12, 2025

Conditions

Keywords

Continuous positive airway pressure

Outcome Measures

Primary Outcomes (1)

  • Functional Outcome of Sleep Questionnaire - Short Form (FOSQ-10)

    FOSQ-10 score ranges between 5 and 20 units; there is not threshold for normality; a higher score indicates higher functional outcome. Outcome Measure: Change from baseline in Functional Outcome of Sleep Questionnaire - Short Form (FOSQ-10), a self-administered disease specific quality of life questionnaire, in participants initiated on CPAP and receiving a 3-month follow-up (LOCF applied using 1-month data). A change in 1 unit is felt to indicate clinical significance.

    3 months

Secondary Outcomes (9)

  • Epworth Sleepiness Scale (ESS)

    3 months

  • Heath Survey Short Form - 12 (SF-12) Physical Component

    3 months

  • Center for Epidemiological Studies Depression Questionnaire (CES-D)

    3 months

  • Insomnia Severity Index (ISI)

    3 months

  • Health Utilities Index (HUI)

    3 months

  • +4 more secondary outcomes

Study Arms (2)

REVAMP

EXPERIMENTAL

Veterans randomized to this arm will have access to the Remote Veteran Apnea Management Platform (REVAMP) a personalized, interactive website that allows Veterans to be evaluated for OSA without travelling to the sleep center.

Device: autoadjusting continuous positive airway pressure

In-person management

ACTIVE COMPARATOR

Veterans randomized to this arm will receive standard in-person management of their sleep apnea in the sleep center.

Device: autoadjusting continuous positive airway pressure

Interventions

Participants in both arms who are diagnosed with obstructive sleep apnea will be treated with autoadjusting continuous positive airway pressure

Also known as: APAP
In-person managementREVAMP

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Referral to one of the participating sleep centers for evaluation of suspected OSA
  • Access in the home to the internet, e-mail, and phone on all days
  • Fluent in English as assessed on the initial phone contact

You may not qualify if:

  • Veterans will be excluded from the study for the following reasons:
  • Unable or unwilling to provide informed consent and complete required questionnaires
  • Previous diagnosis of:
  • obstructive sleep apnea (OSA)
  • central sleep apnea (50% of apneas on diagnostic testing are central apneas)
  • Cheyne-Stokes breathing
  • obesity hypoventilation syndrome
  • narcolepsy
  • Previous treatment with positive airway pressure, non-nasal surgery for OSA, or current use of supplemental oxygen
  • A clinically unstable medical condition in the previous 2 months as defined by a new diagnosis, e.g.:
  • pneumonia
  • myocardial infarction
  • congestive heart failure
  • unstable angina
  • thyroid disease
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

VA San Diego Healthcare System, San Diego, CA

San Diego, California, 92161, United States

Location

Atlanta VA Medical and Rehab Center, Decatur, GA

Decatur, Georgia, 30033, United States

Location

Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA

Philadelphia, Pennsylvania, 19104, United States

Location

Related Publications (1)

  • Chang YHA, Folmer RL, Shasha B, Shea JA, Sarmiento K, Stepnowsky CJ, Lim D, Pack A, Kuna ST. Barriers and facilitators to the implementation of a novel web-based sleep apnea management platform. Sleep. 2021 Apr 9;44(4):zsaa243. doi: 10.1093/sleep/zsaa243.

    PMID: 33216916BACKGROUND

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Limitations and Caveats

The last participant seen/received an intervention on January 31, 2021.

Results Point of Contact

Title
Samuel T. Kuna, MD
Organization
Corporal Michael J. Crescenz VA Medical Center

Study Officials

  • Samuel T. Kuna, MD

    Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 29, 2016

First Posted

January 2, 2017

Study Start

October 24, 2017

Primary Completion

January 31, 2021

Study Completion

January 31, 2021

Last Updated

May 20, 2025

Results First Posted

April 29, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations